Fatima Cody Stanford, M.D., an obesity medicine physician at Massachusetts General Hospital and associate professor at Harvard Medical School
For instance, diabetes mellitus has been described in several IMDs, such as hemochromatosis, aceruloplasminemia, mitochondrial diseases, and GSD type I and III ( While for some IMDs the endocrine system disturbances in children or adolescents are extensively described in the literature, together with well-defined treatment guidelines, for others data remain controversial or clear management recommendations are lacking
Neurochemical Research, 34(6), 10211029
If the employer did not opt in, weight-loss Wegovy is excluded this is a benefit design decision, not a medical-necessity denial, and appeals will not succeed